A new study suggests that specialty care for treating multidrug-resistant tuberculosis (MDRTB) reduces mortality rates by more than half. The findings appear in the August Chest.
The study examined all MDRTB cases (n = 81) reported in Florida from January 1994 to July 1997. The outcomes of patients treated at least partially in a specialty treatment center were compared with those treated only in outpatient community care.
"We found that intensive, specialized care for MDRTB resulted in dramatic reductions in mortality," said David Ashkin, study author and medical executive director at A. G. Holley State Tuberculosis Hospital in Lantana, Fla. "Forty-five percent of patients who received care in a community care setting died vs 18% of patients who received care in the inpatient specialty treatment facility."
Mitka M. Better TB Treatment. JAMA. 2001;286(12):1443. doi:10.1001/jama.286.12.1443-JQU10008-3-1
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: